Canos is bringing a human-grade liquid biopsy platform for dogs, starting with a single blood draw. We sequence cell-free DNA to perform multi-modal analysis of fragmentation, copy number variation, native methylation (5mC and 5hmC) and more to detect cancer signals.
Canos is a Y Combinator company in the Fall 2026 batch. Its directory entry describes it as: AI-powered blood test to detect cancer in dogs (and cats soon). The founder listed is Ming-shan Tsai (Founder/CEO) (Y Combinator directory entry, October 24, 2026).
Sell to companies like Canos? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New accelerator entry · 2026-10-24 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Canos.
Free to see. No signup.
More on Canos and the records around it.
Same batch, Healthcare first.
Get an email when Canos changes status, grows its team or files a funding notice. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Canos raises, hires or launches. No email unless you switch it on.
Watch Canos →Get the full cited report on Canos
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Canos: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
Canos is bringing a human-grade liquid biopsy platform for dogs, starting with a single blood draw. We sequence cell-free DNA to perform multi-modal analysis of fragmentation, copy number variation, native methylation (5mC and 5hmC) and more to detect cancer signals. Owners bank a healthy baseline for their dog and track changes every year. Dogs already diagnosed get personalized monitoring through treatment. We partner with mobile vets and vet clinics to serve SF and NYC. Our mission is to make pet cancer curable through early detection and monitoring.
Checked away from the directory entry. What is below does not come from the company's Y Combinator page.
Human-grade cancer care for dogs. Origin combines cancer detection with a genomic health baseline. OncoTrack follows treatment response and MRD. Blood draws are open.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Founder/CEO at Canos. Previously co-founded and CSO of ZYTCA, built the best team in animal health, and launched multiple veterinary diagnostic products from 0 to 1, including an AI-driven digital pathology system distributed to 10,000+ vet clinics in China. Pivoted from business management to an Oxford biology PhD, from human health to animal health, and from infectious disease to cancer. I'm unstoppable when it comes to solving problems for animals. Our pets deserve the best tech.
Founders, titles and bios as the company published them. Photographs are our own copies of the ones on that record, so they do not break when the original link expires.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Canos: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Canos covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist CanosYou get an alert in MentionFox the next time this company shows up.
If you're behind Canos: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry, and from the company's own site, read directly on 2026-10-25 (canos.ai).
Each opens in a new tab, filled in for Canos. With no account yet, you sign up free and land on the result.
Share the news. Sharing needs no account.
https://mentionfox.com/funding/yc-canos